The FTO inhibitors R-2HG and FB23-2 can inhibit the growth of leukemia cells and slow the progression of leukemia; FB23-2 is more effective and can significantly inhibit acute myeloid leukemia progression in xenograft mice [163,164]. Here, FTO is linked to leukemia.